ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, featuring promising progress throughout various health-related and industrial purposes. With its structural similarity to The natural way derived human serum albumin, OsrHSA provides a safer, much more reliable substitute for therape